Internal Bra Mesh Lawsuit

Thousands of women who underwent internal bra breast surgery are now experiencing serious complications from the surgical mesh placed inside them, and many are pursuing legal action against the manufacturers that promoted these products for a use the FDA never approved.

Breast mesh lawsuits allege that manufacturers of products such as AlloDerm, GalaFLEX, Phasix, and AlloMax marketed their devices for breast reconstruction, augmentation, and revision surgeries even though those applications had never been adequately studied or approved by the FDA. Patients were not warned. Surgeons were not given enough information. So when complications developed, including infection, mesh failure, chronic pain, and the need for additional surgery, most women did not have the information to connect the dots from their problems to the problems with the devices.

This page explains the internal bra mesh lawsuit in plain English: what the legal claims are, who may be eligible, what complications may qualify, and what these cases may be worth.

What Is Breast Mesh and How Is It Used in the Internal Bra Technique?

The surgical mesh used in breast surgery is a material implanted inside the breast to provide structural support for tissue and implants. The surgical technique that uses it is commonly called the internal bra, a self-explanatory term that describes how the mesh functions. Positioned beneath or over breast tissue, the mesh supports the breast from within, in the same way a physical bra supports it from outside.

Women use this internal bra procedure for three reasons.  First, breast reconstruction surgery following a mastectomy, most often after a cancer diagnosis. Second, breast augmentation, where mesh is used to support implants and maintain shape over time. Third, revision or breast lift surgery, where mesh is primarily used to correct or improve prior procedures.

There are two broad categories of breast mesh:

  • Biologic Mesh (ADM): Derived from processed human or animal tissue, acellular dermal matrix (ADM) acts as a biological scaffold that the patient’s own tissue gradually incorporates. Common brands include AlloDerm (human) and Strattice (porcine).
  • Synthetic Mesh:  Made from man-made polymers, synthetic mesh is either resorbable (dissolves over months) or permanent (stays in the body indefinitely). High-selling products that you will see in this litigation include GalaFLEX, Phasix, and DuroSorb.

Women like the idea of mesh in breast surgery because it will hopefully reduce mechanical stress on surrounding tissue and potentially extend the longevity of surgical results.  But there is a wrinkle that creates a problem —  no mesh product has been approved by the FDA for use in breast surgery. That is not a good thing, but if it works without complication, who cares?

But that is the problem.  Studies have found unacceptable complication rates that manufacturers did not adequately disclose.

Breast mesh lawsuits rest on a straightforward legal theory. Manufacturers sold products for breast procedures that were never approved for, vigorously promoted those off-label uses to grow market share, and failed to adequately warn patients or physicians about the real side effects of using mesh in the breast.

Understanding how mesh reached operating rooms begins with the FDA’s 510(k) clearance pathway.  Far too many product liability lawsuits start with this 510(k) sentence.  Because it is an end-run around the usual rules to get a product approved.

Under this process, a medical device can be sold if it is shown to be substantially equivalent to an already-marketed product. This 510(k) clearance does not require proof of safety or effectiveness for any specific clinical application. The mesh products used in internal bra procedures were cleared for general soft-tissue reinforcement, a broad category that does not include breast surgery.

Despite this, manufacturers actively marketed their products for breast procedures. Sales representatives attended surgical conferences. Marketing materials depicted breast surgery applications. Surgeons were encouraged to incorporate mesh into techniques that the FDA had never reviewed, so the device makers would make incredible profits. Patients who underwent those procedures had no reason to suspect that the device placed inside them had been sold for a purpose outside its cleared indication.

Core Allegations in the Breast Mesh Lawsuit

  • Manufacturers failed to conduct adequate clinical studies on mesh safety and effectiveness in breast-specific applications
  • Manufacturers failed to warn surgeons and patients that products were not tested or cleared for use in the breast
  • Manufacturers actively promoted off-label use in breast surgery while patients believed the products had been properly evaluated for that purpose
  • Manufacturers concealed or understated evidence of complication rates that were higher than disclosed

Product liability law, specifically failure-to-warn and defective design claims, forms the backbone of most internal bra cases. Some cases may also assert negligence and fraud claims depending on the circumstances of a patient’s surgery and injury.

FDA Warnings on Breast Mesh: A Timeline

No mesh product has ever received FDA approval for use in breast surgery. Products entered the market through the 510(k) clearance pathway, which only requires showing substantial equivalence to a prior device, not proof of safety or effectiveness in any specific clinical context. Mesh products were cleared for general soft-tissue reinforcement, a category the FDA has never extended to the breast.

2021

FDA issues a safety communication specifically naming FlexHD and AlloMax, warning that data showed significantly higher complication rates with these two ADM brands compared to other options in implant-based breast reconstruction. No recall was issued.

2023

FDA requires Becton, Dickinson and Company (BD) to update warning labels on GalaFLEX, Phasix, and related products. Updated labels explicitly state that these devices have not been studied or cleared for breast reconstructive surgery, marking the first time such a statement appeared on these widely used products.

2026

No breast mesh product holds FDA approval for breast surgery. Breast mesh litigation is accelerating as patients harmed before warning updates were issued continue to file claims. Attorneys are actively investigating cases nationally.

Plaintiffs’ attorneys argue that the FDA’s warnings came years too late for patients already harmed, and that manufacturers were aware of elevated risk data long before the agency intervened. The 2023 label updates, while significant, do nothing for women who had surgery in prior years without the benefit of that information.

Breast Mesh Brands Under Legal Investigation

The following surgical mesh and ADM products are under active legal scrutiny in connection with breast mesh injuries. Manufacturers, including Allergan/LifeCell, Becton Dickinson (BD), C.R. Bard, Integra LifeSciences, and MTF Biologics are named in investigations. If your surgery involved any of these products, you may have grounds for a claim.

Brand / Type Manufacturer FDA Status
AlloDerm
ADM, human
Allergan / LifeCell Not approved for breast surgery
Strattice
ADM, porcine
Allergan / LifeCell Not approved for breast surgery
GalaFLEX
Synthetic, P4HB
Galatea Surgical / BD Label updated Nov. 2023; not approved for breast
Phasix
Synthetic, P4HB
C.R. Bard / BD Label updated Nov. 2023; not approved for breast
DuroSorb
Synthetic, PDO
Integra LifeSciences Not approved for breast surgery
AlloMax
ADM, human
C.R. Bard / BD FDA warning 2021, elevated complication rate
FlexHD
ADM, human
MTF Biologics FDA warning 2021, elevated complication rate

These are just the brands our lawyers are tracking now.  If your mesh brand does not appear on this list, you may still have a viable internal bra lawsuit.  An attorney can review your records and advise you on whether your specific product and injuries qualify.

Who May Qualify to File an Internal Bra Mesh Lawsuit

Women who had surgical mesh placed during breast surgery and later suffered complications may qualify to file a breast mesh lawsuit. You do not need to have every detail before speaking with a lawyer. A case review can help determine whether you may have a claim.

You may qualify if:

1. You had breast reconstruction, augmentation, or revision surgery.

This can include reconstruction after a mastectomy, breast augmentation with implants, or revision and breast lift procedures.

2. Surgical mesh or ADM was used in the procedure.

The product may have been biologic, synthetic, resorbable, or permanent. If you are not sure, your surgical records should identify it, and an attorney can help you get those records.

3. You experienced complications after the surgery.

Potentially qualifying complications may include infection, seroma, mesh failure, chronic pain, breast deformity, capsular contracture, implant loss, or the need for revision surgery.  Do you need to have the mesh removed to bring a claim? No. You also do not need to be in active treatment right now. The key issue is whether you were harmed by a product used in a breast procedure for which it was not approved. That said, many lawyers, including our law firm, are not taking cases unless a revision was done or there are compelling circumstances.

4. You are still within the filing deadline in your state.

The statute of limitations varies by state, often ranging from one to six years from the date of injury or from the date you discovered the injury may be linked to the mesh. A lawyer can tell you what deadline applies in your case.

Internal Bra Complications: What Can Go Wrong

The human body does not always tolerate foreign material. Whether the mesh is biologic or synthetic, the immune system can react, sometimes in the weeks immediately following surgery, and sometimes months or years later. Internal bra mesh complications range from painful and disruptive to permanently life-altering.

A 2024 study published in the Aesthetic Surgery Journal Open Forum found reoperation rates as high as 10% in patients who received mesh during breast procedures. In approximately 3% of patients who received synthetic mesh during breast reconstruction, the implant was lost entirely.

Complication What It Means
Infection and abscess Deep tissue infections that resist antibiotics and frequently require surgical removal of the mesh to resolve
Seroma Chronic fluid buildup around the mesh or implant requiring repeated drainage and ongoing monitoring
Capsular contracture Scar tissue forms and hardens around the implant, causing progressive pain and visible breast deformity
Mesh migration or failure The mesh shifts from its original position or detaches from the tissue it was meant to support
Skin erosion and tissue necrosis In severe cases, mesh wears through surrounding tissue, causing permanent tissue death
Chronic pain and nerve injury Persistent pain, numbness, or hypersensitivity in the breast or chest wall that does not resolve
Implant loss The breast implant must be completely removed due to infection, contracture, or mesh failure

How to Find Out If Mesh Was Used in Your Surgery

Many patients are never explicitly told that mesh was part of their procedure. Surgeons often describe the internal bra technique in general terms without naming specific products, and the details are buried in surgical records that patients rarely think to request.

You can do this yourself or, more likely, your attorney will do it for you.  To identify whether mesh was used and which brand you received:

  • Request your complete operative report from the hospital or surgical center. This document describes exactly what was done during your procedure, including any materials implanted.
  • Look for device implant stickers. Hospitals are required to attach product stickers from implanted devices to the patient’s surgical record. These contain the brand name, product code, and Unique Device Identifier (UDI). Our lawyers will know what they mean.
  • Review your discharge paperwork and any implant documentation cards given to you at the time of surgery.  This is a shortcut to finding the brand, but it is not necessary if you have lost that paperwork.
  • Call your surgeon’s office and ask directly whether mesh or acellular dermal matrix was used and, if so, the specific brand and product name.  They do not always know but it does not hurt to ask.

Your medical records belong to you by law.  We rarely have trouble. If a provider creates obstacles to access, an attorney can issue a formal medical records request on your behalf. Identifying the specific product you received is one of the first steps ourlegal team will take when evaluating your claim.

Evidence That Strengthens a Breast Mesh Claim

Personal injury claims rest on documentation. You do not need everything assembled before speaking with an attorney, but gathering what you can now puts your case in a stronger position from the start.

Medical Records

  • Operative reports from the original surgery
  • Device implant logs with brand, model, and lot number
  • Imaging studies (MRI, ultrasound) and pathology reports
  • All follow-up visit notes documenting complications
  • Records of any revision or removal procedures

Financial and Personal Records

  • Medical bills, pharmacy receipts, out-of-pocket costs
  • Documentation of lost wages or reduced work capacity
  • Personal journal noting symptoms and daily limitations
  • Photographs of visible injuries or physical changes
  • Witness statements from family members or caregivers

Start a symptom journal today if you have not already. Record your symptoms, when they began, how they have changed, how they affect your daily life, and every medical appointment or treatment you have received. A contemporaneous personal record is often one of the most persuasive pieces of evidence in a medical device injury case.

Breast Mesh Lawsuit Settlements and Potential Case Value

We are in the early innings of this litigation. As of early 2026, there are no large-scale breast mesh settlements.  Because the litigation is still developing, specific figures are a real challenge. What is available is context from comparable mesh litigation.

In 2024, C.R. Bard reached a settlement estimated to exceed $1 billion to resolve approximately 40,000 hernia mesh claims. The same manufacturer, Bard, now faces scrutiny over breast mesh products, including AlloMax and Phasix.

These internal bra lawsuits would certainly seem to have higher projected settlement amounts.  While hernia mesh and breast mesh cases involve different injuries and different patient populations, the precedent demonstrates that mesh manufacturers have faced and resolved massive liability when their products caused widespread harm from off-label use.

The value of any individual breast mesh claim depends on several factors:

Factor How It Affects Claim Value
Severity of injury Permanent deformity, tissue necrosis, and implant loss generally yield higher compensation than temporary complications
Revision or removal surgery Cases requiring additional operations to address mesh complications typically carry higher damages
Duration of suffering Longer periods of chronic pain, disability, or diminished quality of life increase claim value
Documented medical costs All documented expenses, including surgeries, medications, physical therapy, and out-of-pocket costs are recoverable
Lost income Lost wages and reduced earning capacity caused by complications factor into total damages
Pain and suffering Non-economic damages for physical pain, emotional distress, and loss of enjoyment of life

Attorneys working on breast mesh cases will have a clearer picture of individual case values after we get to look at the internal documents.  Prediction? They are really bad. Early indications from the internal safety data tell us the manufacturers were significantly more alarmed than what they told the public. So the defendants’ documents could be very incriminating.

From there, if they are bold enough, we will have bellwether trials, early test cases that go to jury verdict, and help establish settlement ranges for victims.  How long will this take?   The reality is this process typically takes two to three years once cases begin to consolidate in federal or state court.

Frequently Asked Questions About Breast Mesh Lawsuits

Is surgical mesh FDA-approved for breast surgery?

No, and this is a key point you are going to see over and over in the breast mesh litigation. Not a single mesh product, whether biologic ADM or synthetic, has been approved by the FDA for use in breast surgery.  Yet our laws technically allow it. Products were cleared under a pathway designed for general soft-tissue repair, the 510(k) we talk about above, and that clearance has never been extended to breast-specific procedures.

What if my mesh was resorbable? Can I still file a lawsuit?

Yes. Resorbable mesh dissolves over time, but complications from that mesh, including infection, seroma, and tissue reactions, happen all the time with women we have spoken with. If you suffered harm from resorbable breast mesh, the fact that the material has since dissolved does not extinguish your right to pursue a claim.

Do I need mesh removal surgery to be eligible?

No. Mesh removal is not a requirement. If you experienced qualifying complications, including infection, chronic pain, seroma, breast deformity, capsular contracture, or implant loss, you may be eligible regardless of whether the mesh was surgically removed.  Our law firm, however, is only taking cases with a revision or some compelling injury.

How long do I have to file an internal bra mesh lawsuit?

Deadlines vary by state. Statutes of limitations for personal injury claims typically range from one to six years, starting from the date you were injured or the date you discovered, or reasonably should have discovered, that your injury was linked to the mesh.

That “should reasonably have discovered” language, you are going to see a lot when we are bringing older lawsuits.  This is called the “discovery rule” and it puts a little bit of “fair” in what is a very harsh and unforgiving statute of limitations rule.

The real message is that the statute of limitations is a whole lot more complicated than it looks. Missing this deadline permanently bars your right to recover compensation. Our attorneys talk to victims all the time who have a claim when they do not think they do.  Conversely, our lawyers also talk to a lot of victims who do not have a claim when they think they do.

What is the solution? So speak with an attorney as soon as possible to confirm the deadline that applies to your situation.

My surgeon told me the mesh was safe. Does that matter?

If your surgeon told you the mesh was safe, that could paradoxically help your breast mesh lawsuit.  Surgeons who used these products often had no reason to doubt them. Why? Because, again, manufacturers did not provide adequate warnings about breast-specific risks. In many cases, surgeons were themselves misled by marketing that implied broader clearance than the products actually held. The legal claims in breast mesh litigation are directed primarily at manufacturers, not treating physicians.

What does it cost to speak with a breast mesh attorney?

Nothing. Almost all attorneys handling breast mesh cases work on a contingency fee basis. You pay no legal fees unless your case results in a recovery. An initial case evaluation costs you nothing and carries no obligation. This gives victims a chance to find the best breast mesh lawyer they can find without worrying about out-of-pocket expenses.

Hiring an Internal Bar Mesh Lawyer

If you believe you have a claim in this litigation, our law firm wants to help you.  Call 800-553-8082 or get a free, no obligation consultation online.